Business Wire

Protegrity Data Protection Platform and Cloud Protect for Snowflake Now Available in the Microsoft Azure Marketplace

18.11.2021 17:00:00 EET | Business Wire | Press release

Share

Protegrity, a global leader in data security, today announced the availability of the Protegrity Data Protection Platform and Cloud Protect for Snowflake in the Microsoft Azure Marketplace, an online store providing applications and services for use on Microsoft Azure. Protegrity customers can now take advantage of the scalability, high availability, and security of Azure, with streamlined deployment and management.

Additionally, Protegrity has achieved Microsoft’s stringent Co-Sell Ready designation, unlocking the development of joint solutions, sales, and support through the Microsoft One Commercial Partner Program. Protegrity has also joined the Microsoft FastTrack certification program.

“Due to heightened sensitivity over data and privacy, many organizations have been slower to adopt cloud solutions,” said Jay Chitnis, vice president, global alliances and partners at Protegrity. “However, we’re now seeing a tipping point with businesses. Many of them want to make the most of the cloud to support AI and machine learning initiatives, so they can gain valuable insights from data, but they also recognize they have to safeguard the privacy of their customers, partners, and employees. That’s why it’s critical for organizations to secure data in any form and wherever it is—in the cloud or on premises—so it can be accessed across the enterprise by front-line employees, analytics teams, and anyone who needs data intelligence to make business decisions. Our collaboration with Microsoft ensures our mutual customers’ data is not at risk as it moves to the cloud, allowing organizations to accelerate cloud adoption.”

Jake Zborowski, general manager, Microsoft Azure Platform at Microsoft Corp., said, “We’re pleased to welcome Protegrity's solutions to the Microsoft Azure Marketplace, which gives our partners great exposure to cloud customers around the globe. Azure Marketplace offers world-class quality experiences from global trusted partners with solutions tested to work seamlessly with Azure.”

The Azure Marketplace is an online market for buying and selling cloud solutions certified to run on Azure. The Azure Marketplace helps connect companies seeking innovative, cloud-based solutions with partners who have developed solutions that are ready to use.

Seamless Data Protection to Support Advanced Analytics, AI, and Machine Learning on Microsoft Azure

As part of the Co-Sell Ready achievement, Protegrity met Microsoft’s strict architecture and security requirements. Protegrity will also continue to work with Microsoft account teams and partners to seamlessly deliver modern data protection and data privacy solutions to joint customers while supporting advanced analytics, AI, and machine learning, and Microsoft Azure cloud initiatives. Additionally, as part of the FastTrack program, Protegrity’s commitment to Microsoft Azure-based solutions will provide native security and performance for mutual customers.

Protegrity’s enterprise-class Data Protection Platform integration with Microsoft Azure enables customers to apply data-protection policies across different environments, entities, and jurisdictions. Additionally, customers are able to:

  • Secure data moving to the cloud to reduce operational risk;
  • Govern data in the cloud leveraging enterprise-wide information security policies; and
  • Unlock and secure data analytics capabilities in the cloud.

Built for hybrid-cloud and multi-cloud, the Protegrity Data Protection Platform allows companies to seamlessly deploy and update data security policies across geographies, departments, and digital transformation programs. Businesses can quickly and safely turn sensitive data into intelligence-driven insights to deliver better customer experiences, monetize data responsibly, and support AI and machine learning initiatives.

Protegrity Data Protection Platform and Cloud Protect for Snowflake on Microsoft Azure Safeguard Sensitive Data for Privacy Compliance

Now available on the Microsoft Azure Marketplace, the Protegrity Data Protection Platform provides customers with fine-grained data protection capabilities for sensitive data and compliance. Protegrity accelerates analytics; minimizes risk in enterprise cloud adoption and migration; and meets storage, big data, and workload requirements. With its format-preserving vaultless tokenization capabilities and other forms of encryption, Protegrity safeguards data throughout every step of the data lifecycle.

Protegrity also announced the availability of Cloud Protect for Snowflake, which bundles two serverless components, the Snowflake Protector and Cloud API, to protect customers’ data and accelerate cloud migration and adoption of Snowflake.

  • Snowflake Protector: The Snowflake Protector is a purpose-built protector that integrates seamlessly with Snowflake SQL to easily protect and unprotect sensitive data. Elastically scalable and benchmarked for high performance, the Protegrity Snowflake Protector enables organizations to support even the largest workloads.
  • Cloud API: The Cloud API provides a general tokenization REST endpoint for use within ETL workflows. It can be used to protect data prior to ingestion into Snowflake, ensuring that data is always protected at rest.

With its support for Microsoft Azure, Protegrity continues to deliver on its commitment to expand cloud-inclusivity, enabling customers to maintain enterprise-wide data protection wherever sensitive data resides. Support for Microsoft points to one of many integrations Protegrity has with cloud providers as part of the new Protegrity Partner Network—a collaboration with leading technology companies that enables organizations to protect data in the cloud, regardless of vendor. With the freedom to safeguard data in any cloud system or application, organizations can unlock the potential of secure data no matter where it is and create more opportunities for innovation and digital transformation and improve customer experiences.

Learn more

Website: protegrity.com
Twitter: @Protegrity
LinkedIn: linkedin.com/company/protegrity

About Protegrity

Protegrity, a global leader in data security, protects sensitive data everywhere and future-proofs businesses as data-privacy regulations evolve. Maintaining privacy today across distributed data has become impossibly complicated. With Protegrity, enterprises can secure data wherever it resides, control how it’s protected, and have confidence that data is safe, even if a breach occurs. The Protegrity Data Protection Platform is a modern alternative to traditionally complex data-protection methods that leave gaps in security. Whether encrypting, tokenizing, or applying privacy models, Protegrity protects data at the speed of business. Deep integrations with Snowflake, Amazon Redshift, Teradata, Oracle, Microsoft SQL Server, Cloudera, Databricks, and many other enterprise applications ensure that data remains fully protected in hybrid-cloud, multi-cloud, and on-premises environments. The platform’s fine-grained data protection anonymizes personally identifiable information (PII) that’s used in AI and machine learning models, providing faster access to critical analytics data and dramatically shortening the time to business insights. Protegrity protects the sensitive data of more than two billion individuals across global enterprises, including four of the world’s 15 largest banks, four out of 10 of the top health insurance providers, and three of the world’s leading multinational companies. With more than two decades of industry-leading innovation, Protegrity allows businesses to finally tap into the value of their data and accelerate digital transformation timelines – without jeopardizing individuals’ fundamental right to privacy.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Andrew Smith
Bhava Communications for Protegrity
protegrity@bhavacom.com
+1 (310) 941-7251

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye